Activin a promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells

Stem Cells and Development

Volumn 21, Issue 15, 2012, Pages 2866-2877

  Cerdan, Chantal ^a   McIntyre, Brendan A S ^a   Mechael, Rami ^a,b   Levadoux Martin, Marilyne ^a   Yang, Jiabi ^a   Lee, Jung Bok ^a   Bhatia, Mickie ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR; HEMOPOIETIC GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR PAX6; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; COLONY FORMATION; EMBRYOID BODY; EMBRYONIC STEM CELL; GASTRULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; PRIMITIVE STREAK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIVINS; ANIMALS; ANTIGENS, DIFFERENTIATION; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYOID BODIES; FETAL PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE KNOCKDOWN TECHNIQUES; HEMATOPOIESIS; HUMANS; MESODERM; MICE; RNA INTERFERENCE; T-BOX DOMAIN PROTEINS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

AMPHIBIA;

EID: 84870396349     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0053     Document Type: Article

References (62)

1. Smith JC, BM Price, JB Green, D Weigel and BG Herrmann. (1991). Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response tomesoderminduction.Cell 67:79-87.
2. Schulte-Merker S, FJ van Eeden, ME Halpern, CB Kimmel and C Nusslein-Volhard. (1994). no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene. Development 120:1009-1015.
3. Kispert A, H Ortner, J Cooke and BG Herrmann. (1995). The chick Brachyury gene: developmental expression pattern and response to axial induction by localized activin. Dev Biol 168:406-415.
4. Herrmann BG, S Labeit, A Poustka, TR King and H Lehrach. (1990). Cloning of the T gene required in mesoderm formation in the mouse. Nature 343:617-622.
5. Huber TL, Y Zhou, PE Mead and LI Zon. (1998). Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood 92:4128-4137.
6. Lacaud G, G Keller and V Kouskoff. (2004). Tracking mesoderm formation and specification to the hemangioblast in vitro. Trends Cardiovasc Med 14:314-317.
7. Izumi N, T Era, H Akimaru, M Yasunaga and S Nishikawa. (2007). Dissecting the molecular hierarchy for mesendoderm differentiation through a combination of embryonic stem cell culture and RNA interference. Stem Cells 25:1664-1674.
8. Schnerch A, C Cerdan and M Bhatia. (2010). Distinguishing between mouse and human pluripotent stem cell regulation: the best laid plans of mice and men. Stem Cells 28:419-430.
9. Chadwick K, L Wang, L Li, P Menendez, B Murdoch, A Rouleau and M Bhatia. (2003). Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906-915.
10. Cerdan C, A Rouleau and M Bhatia. (2004). VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 103:2504-2512.
11. Wang L, P Menendez, C Cerdan and M Bhatia. (2005). Hematopoietic development from human embryonic stem cell lines. Exp Hematol 33:987-996.
12. Wang L, L Li, F Shojaei, K Levac, C Cerdan, P Menendez, T Martin, A Rouleau and M Bhatia. (2004). Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21:31-41.
13. Vijayaragavan K, E Szabo, M Bosse, V Ramos-Mejia, RT Moon and M Bhatia. (2009). Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 4:248-262.
14. Zambidis ET, B Peault, TS Park, F Bunz and CI Civin. (2005). Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106:860-870.
15. Fehling HJ, G Lacaud, A Kubo, M Kennedy, S Robertson, G Keller and V Kouskoff. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-4227.
16. Tian X and DS Kaufman. (2008). Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Curr Opin Hematol 15:312-318.
17. Huber TL, V Kouskoff, HJ Fehling, J Palis and G Keller. (2004). Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432:625-630.
18. Lancrin C, P Sroczynska, C Stephenson, T Allen, V Kouskoff and G Lacaud. (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457:892-895.
19. Smith JC, V Cunliffe, JB Green and HV New. (1993). Intercellular signalling in mesoderm formation during amphibian development. Philos Trans R Soc Lond B Biol Sci 340:287-296.
20. Bendall SC, MH Stewart, P Menendez, D George, K Vijayaragavan, T Werbowetski-Ogilvie, V Ramos-Mejia, A Rouleau, J Yang, et al. (2007). IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448:1015-1021.
21. Vallier L, M Alexander and RA Pedersen. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118:4495-4509.
22. Kubo A, K Shinozaki, JM Shannon, V Kouskoff, M Kennedy, S Woo, HJ Fehling and G Keller. (2004). Development of definitive endoderm from embryonic stem cells in culture. Development 131:1651-1662.
23. D'Amour KA, AD Agulnick, S Eliazer, OG Kelly, E Kroon and EE Baetge. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23:1534-1541.
24. McLean AB, KA D'Amour, KL Jones, M Krishnamoorthy, MJ Kulik, DM Reynolds, AM Sheppard, H Liu, Y Xu, EE Baetge and S Dalton. (2007). Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25:29-38.
25. Hay DC, J Fletcher, C Payne, JD Terrace, RC Gallagher, J Snoeys, JR Black, D Wojtacha, K Samuel, et al. (2008). Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA 105:12301-12306.
26. Sulzbacher S, IS Schroeder, TT Truong and AM Wobus. (2009). Activin A-induced differentiation of embryonic stem cells into endoderm and pancreatic progenitors-The influence of differentiation factors and culture conditions. Stem Cell Rev 5:159-173.
27. Bernardo AS, T Faial, L Gardner, KK Niakan, D Ortmann, CE Senner, EM Callery, MW Trotter, M Hemberger, et al. (2011). BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell 9:144-155.
28. Shav-Tal Y and D Zipori. (2002). The role of activin a in regulation of hemopoiesis. Stem Cells 20:493-500.
29. Allouche M and A Bikfalvi. (1995). The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Prog Growth Factor Res 6:35-48.
30. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
31. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974.
32. Hong SH, JH Lee, JB Lee, J Ji and M Bhatia. (2011). ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J Cell Sci 124:1445-1452.
33. Ben-Dor I, P Itsykson, D Goldenberg, E Galun and BE Reubinoff. (2006). Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells. Mol Ther 14:255-267.
34. Latinkic BV, M Umbhauer, KA Neal, W Lerchner, JC Smith and V Cunliffe. (1997). The Xenopus Brachyury promoter is activated by FGF and low concentrations of activin and suppressed by high concentrations of activin and by pairedtype homeodomain proteins. Genes Dev 11:3265-3276.
35. Symes K, C Yordan and M Mercola. (1994). Morphological differences in Xenopus embryonic mesodermal cells are specified as an early response to distinct threshold concentrations of activin. Development 120:2339-2346.
36. Green JB, HV New and JC Smith. (1992). Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71:731-739.
37. Pick M, L Azzola, A Mossman, EG Stanley and AG Elefanty. (2007). Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 25:2206-2214.
38. Zhang P, J Li, Z Tan, C Wang, T Liu, L Chen, J Yong, W Jiang, X Sun, L Du, M Ding and H Deng. (2008). Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 111:1933-1941.
39. Vallier L, T Touboul, Z Chng, M Brimpari, N Hannan, E Millan, LE Smithers, M Trotter, P Rugg-Gunn, A Weber and RA Pedersen. (2009). Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 4:e6082.
40. Nishikawa SI, S Nishikawa, M Hirashima, N Matsuyoshi and H Kodama. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE-cadherin + cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
41. Cornell RA, TJ Musci and D Kimelman. (1995). FGF is a prospective competence factor for early activin-type signals in Xenopus mesoderm induction. Development 121:2429-2437.
42. Cornell RA and D Kimelman. (1994). Activin-mediated mesoderm induction requires FGF. Development 120:453-462.
43. Willems E and L Leyns. (2008). Patterning of mouse embryonic stem cell-derived pan-mesoderm by Activin A/Nodal and Bmp4 signaling requires Fibroblast Growth Factor activity. Differentiation 76:745-759.
44. Gerdes J, H Lemke, H Baisch, HH Wacker, U Schwab and H Stein. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715.
45. Yamada G, C Kioussi, FR Schubert, Y Eto, K Chowdhury, F Pituello and P Gruss. (1994). Regulated expression of Brachyury( T), Nkx1.1 and Pax genes in embryoid bodies. Biochem Biophys Res Commun 199:552-563.
46. Isaacs HV, ME Pownall and JM Slack. (1994). eFGF regulates Xbra expression during Xenopus gastrulation. EMBO J 13:4469-4481.
47. Wardle FC and JC Smith. (2004). Refinement of gene expression patterns in the early Xenopus embryo. Development 131:4687-4696.
48. Terzic J and M Saraga-Babic. (1999). Expression pattern of PAX3 and PAX6 genes during human embryogenesis. Int J Dev Biol 43:501-508.
49. Smith JR, L Vallier, G Lupo, M Alexander, WA Harris and RA Pedersen. (2008). Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 313:107-117.
50. Kavka AI and JB Green. (1997). Tales of tails: Brachyury and the T-box genes. Biochim Biophys Acta 1333:F73-F84.
51. Era T, N Izumi, M Hayashi, S Tada and S Nishikawa. (2008). Multiple mesoderm subsets give rise to endothelial cells, whereas hematopoietic cells are differentiated only from a restricted subset in embryonic stem cell differentiation culture. Stem Cells 26:401-411.
52. Eiselleova L, K Matulka, V Kriz, M Kunova, Z Schmidtova, J Neradil, B Tichy, D Dvorakova, S Pospisilova, A Hampl and P Dvorak. (2009). A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 27:1847-1857.
53. Cunliffe V and JC Smith. (1992). Ectopic mesoderm formation in Xenopus embryos caused by widespread expression of a Brachyury homologue. Nature 358:427-430.
54. Nostro MC, X Cheng, GM Keller and P Gadue. (2008). Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2:60-71.
55. Faloon P, E Arentson, A Kazarov, CX Deng, C Porcher, S Orkin and K Choi. (2000). Basic fibroblast growth factor positively regulates hematopoietic development. Development 127:1931-1941.
56. Gadue P, TL Huber, MC Nostro, S Kattman and GM Keller. (2005). Germ layer induction from embryonic stem cells. Exp Hematol 33:955-964.
57. Pearson S, P Sroczynska, G Lacaud and V Kouskoff. (2008). The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 135:1525-1535.
58. Irion S, RL Clarke, H Luche, I Kim, SJ Morrison, HJ Fehling and GM Keller. (2010). Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development 137:2829-2839.
59. Ramos-Mejia V, GJ Melen, L Sanchez, I Gutierrez-Aranda, G Ligero, JL Cortes, PJ Real, C Bueno and P Menendez. (2010). Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther 18:2173-2181.
60. Hong SH, S Rampalli, JB Lee, J McNicol, T Collins, JS Draper and M Bhatia. (2011). Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell 9:24-36.
61. Guezguez B and M Bhatia. (2008). Transplantation of human hematopoietic repopulating cells: mechanisms of regeneration and differentiation using human-mouse xenografts. Curr Opin Organ Transplant 13:44-52.
62. Bhatia M. (2007). Hematopoietic development from human embryonic stem cells. Hematol Am Soc Hematol Educ Program: 11-16.